If mornings now begin with stiff knees, achy hips or hands that need a minute to get going, you're far from alone. More than ...
Shares of Immunovant surged in premarket trading Wednesday after the company reported positive preliminary trial data for its IMVT-1402 drug candidate in rheumatoid arthritis, despite widening its ...
Experts say biomarker research and multiomics are pushing rheumatology toward more individualized treatment strategies and earlier disease classification.
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
I spoke with orthopedic surgeons and doctors to find the best knee braces for arthritis that diminish joint pain and support ...
TAKING a common arthritis drug could be more effective than antidepressants in helping to cure depression, a study suggests.
UCB’s Bimzelx elicited significantly stronger joint relief at 16 weeks than AbbVie’s Skyrizi in a Phase 3 head-to-head study ...
The methotrexate drugs market is driven by rising autoimmune disease prevalence, technological advances in drug delivery, and ...
Immunovant reports clinically meaningful trial results for its lead drug candidate. That’s good news for Roivant Sciences.
Could regenerative medicine heal damaged joints naturally? Experts explain how advanced therapies are changing pain relief ...
Women are less likely to stay on TNF and IL-17 inhibitors compared with men, according to findings of a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results